Botulism - Prevention, clinical diagnostics, therapy and possible threat;Botulismus - Prävention, diagnostik, therapie und mögliche bedrohungslagen

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 16, 2008, Pages 840-845

  Gutzwiller, F S ^a   Steffen, R ^a   Mathys, P ^b   Walser, S ^b   Schmid, H ^b   Mütsch, Margot ^a,c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Bundesamt fur Gesundheit   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Bioterrorism; Botulinum toxin; Clostridium botulinum; Food borne botulism; Neuroparalysis; Neurotoxin; Wound botulism

Indexed keywords

ANTIBIOTIC AGENT; BOTULINUM ANTISERUM; HUMAN IMMUNOGLOBULIN; BOTULINUM TOXIN;

ANAMNESIS; BOTULISM; CLINICAL PRACTICE; CLOSTRIDIUM BOTULINUM; DIFFERENTIAL DIAGNOSIS; HUMAN; PATHOGENESIS; REVIEW; TREATMENT CONTRAINDICATION; ADULT; GERMANY; INCIDENCE; SWITZERLAND;

ADULT; BOTULINUM TOXINS; BOTULISM; CLOSTRIDIUM BOTULINUM; GERMANY; HUMANS; INCIDENCE; SWITZERLAND;

EID: 42449112895     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1075658     Document Type: Review

References (57)

1. American Academy of Pediatrics. Antibodies of Animal Origin (Animal Antisera). Red Book 2006; 2006: 61-64
2. Angulo FJ, Getz J, Taylor JP et al. A large outbreak of botulism: the hazardous baked potato. J Infect Dis 1998; 178: 172-177
3. Arnon SS, Schechter R, Inglesby TV et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001; 285: 1059-1070
4. Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006; 354: 462-471
5. Ashkenazi A, Silberstein SD. Botulinum toxin and other new approaches to migraine therapy. Annu Rev Med 2004; 55: 505-518
6. Aventis Pasteur. Package insert Botulism Antitoxin Bivalent (Equine) Types A and B. USA: August 1997
7. BGH. Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (IfSG). Veröffentlicht im BGBl. I Seite 1045 vom 20.07.2000
8. Bossi P. Bichat-Leitlinien zur klinischen Behandlung von Botulismus und mit Bioterrorismus zusammenhängendem Botulismus. Eurosurveillance 2004
9. CDC. Available from: http://www.cdc.gov/od/ohs/biosfty/bmbl4/ bmbl4toc.htm. Biosafety in Microbiological and Biomedical Laboratories (BMBL) 4th Edition. 1999[accessed November 10, 2005]
10. CDC. Available from: http://www.bt.cdc.gov/agent/botulism/index. asp. Botulism in the United States, 1899-1996. Handbook for epidemiologists, clinicians, and laboratory workers. 1998[accessed November 4, 2005]
11. CDC. NCfID. Available from: http://www.cdc.gov/ncidod/dbmd/ disease-info/botulism_g.htm. Botulism - General Information. 2005[accessed November 4, 2005]
12. Chia JK, Clark JB, Ryan CA, Pollack M. Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N Engl J Med 1986; 315: 239-241
13. CIDRAP. Available from: http://www.cidrap.umn.edu/cidrap/content/ bt/botulism/biofacts/botulismfactsheet.html. Botulism: current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis and treatment. [accessed August 18, 2007]
14. Committee on Environmental Health and Committee on Infectious Diseases. Chemical-Biological Terrorism and Its Impact on Children: A Subject Review. Pediatrics 2000; 105: 662-670
15. Czaplinski A, Radziwill AJ, Graber P, Fuhr P, Steck AJ. Diagnostische Aspekte des Botulismus. Akt Neurol 2002; 29: 76-82
16. Eitner C. Persönliche Kommunikation. Berlin, Deutschland: Robert Koch-Institut, 04 July 2007
17. Erbguth FJ, Naumann M. Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the "sausage poison". Neurology 1999; 53: 1850-1853
18. Fenicia L, Franciosa G, Pourshaban M, Aureli P. Intestinal toxemia botulism in two young people, caused by Clostridium butyricum type E. Clin Infect Dis 1999; 29: 1381-1387
19. Foran PG, Mohammed N, Lisk GO et al. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 2003; 278: 1363-1371
20. Franz DR, Jahrling PB, Friedlander AM et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278: 399-411
21. Hächler H. Persönliche Kommunikation. Nationales Zentrum für enteropathogene Bakterien (NENT). Bern, Schweiz: Institut für Veterinärbakteriologie der Universität Bern, 15 Dec 2005
22. Holzer E. Botulismus durch Inhalation. Med Klin 1962; 57: 1735-1738
23. Hooper RR. The covert use of chemical and biological warfare against United States Strategic Forces. Mil Med 1983; 148: 901-902
24. Kalluri P, Crowe C, Reller M et al. An outbreak of foodborne botulism associated with food sold at a salvage store in Texas. Clin Infect Dis 2003; 37: 1490-1495
25. Kerner J. Das Fettgift oder die Fettsäure und ihre Wirkungen auf den thierischen Organismus, ein Beytrag zur Untersuchung des in verdorbenen Würsten giftig wirkenden Stoffes. Tübingen (Deutschland): Cotta, 1822
26. Kerner J. Neue Beobachtungen über die in Württemberg so häufig vorfallenden tödlichen Vergiftungen durch den Genuss geräucherter Würste. Tübingen (Deutschland): Osiander, 1820: 120
27. Kerner J. Vergiftung durch verdorbene Würste. Tübinger Blätter für Naturwissenschaften und Arzneykunde 1817; 3: 1-25
28. Kuhn J, Gerbershagen K, Schaumann R et al. Wundbotulismus bei Heroinabhängigen in Deutschland. Dtsch med Wochenschr 2006; 131: 1023-1028
29. Lamanna C. The most poisonous poison. Science 1959; 130: 763-772
30. Landesgesundheitsamt Baden-Württemberg. BLUE BOOK. Vorsorge und medizinisches Management von Verletzungen durch biologische Waffen; 2002
31. Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment? Ann Intern Med 2006; 145: 599-609
32. Novartis Behring. Fachinformation Botulismus-Antitoxin Behring Trivalent (equin) Typen A, B und E. (Deutschland): September 2006
33. Rajkumar GN, Small DR, Mustafa AW, Conn G. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 2005; 96: 848-852
34. Robert Koch Institut. Available from: www.rki.de. Botulismus Fallzahlen in Deutschland. 2001-2005[accessed March 10, 2007]
35. Robinson RF, Nahata MC. Management of botulism. Ann Pharmacother 2003; 37: 127-131
36. Rote Liste. Available from: http://www.rote-liste.de/Online/texte/ notfalldepot.html. Notfalldepots. 2008[accessed January 23, 2008]
37. Schechter R, Arnon SS. Commentary: where Marco Polo meets Meckel: type E botulism from Clostridium butyricum. Clin Infect Dis 1999; 29: 1388-1393
38. Schneider C. Persönliche Kommunikation. Langen, Deutschland: Paul-Ehrlich-Institut, 01 Feb 2007
39. Schweizerisches Toxikologisches Informationszentrum. Available from: http://www.toxi.ch/. [accessed January 13, 2008]
40. Sclafani AP, Kwak E. Alternative management of the aging jawline and neck. Facial Plast Surg 2005; 21: 47-54
41. Shapiro RL, Hatheway C, Becher J, Swerdlow DL. Botulism surveillance and emergency response. A public health strategy for a global challenge. JAMA 1997; 278: 433-435
42. Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: A Clinical and Epidemiologic Review. Ann Intern Med 1998; 129: 221-228
43. Simpson LL. Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 2004; 44: 167-193
44. Smith LDS. Botulism: The Organism, Its Toxins, The Disease. 2nd edition. Springfield (USA): Charles C. Thomas, Publisher Ltd, 1988
45. Smithson A. Available from: http://www.stimson.org/?SN= CB2001121785. Toxic Archipelago: Preventing Proliferation From the Former Soviet Chemical and Biological Weapons Complexes. Report No. 32. 1999[accessed 24. Nov 2005]
46. Sobel J. Botulism. Clin Infect Dis 2005; 41: 1167-1173
47. Sotos JG. Botulinum Toxin in Biowarfare. JAMA 2001; 285: 2716-2716
48. Todar K. Available from: http://textbookofbacteriology.net/ clostridia.html. Todar's Online Textbook of Bacteriology. 2005[accessed 02 Feb, 2006]
49. Truong D, Duane DD, Jankovic J et al. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord 2005; 20: 783-791
50. United Nations Security Council. Available from: http://www.un.org/Depts/unscom/sres95-1038.htm. Tenth Report of the Executive Chairman of the Special Commission Established by the Secretary-General Pursuant to Paragraph 9(b)(I) of Security Council Resolution 687 (1991), and Paragraph 3 of Resolution 699 (1991) on the Activities of the Special Commission. 1995[accessed 23. Nov 2005]
51. USAMRIID. Available from: http://www.usamriid.army.mil. Medical Management of Biological Casualties Handbook. [accessed 02. Jan 2008]
52. van Ermengen E. Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Zeitschrift für Hygiene und Infektionskrankheiten 1897; 26: 1-56
53. Wein LM, Liu Y. Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk. Proc Natl Acad Sci USA 2005; 102: 9984-9989
54. Werner SB, Passaro D, McGee J, Schechter R, Vugia DJ. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin Infect Dis 2000; 31: 1018-1024
55. WHO. Available from: http://www.who.int/csr/en/. Epidemic and Pandemic Alert and Response. 2005[accessed March 28, 2006]
56. Wiener SL. Strategies for the prevention of a successful biological warfare aerosol attack. Mil Med 1996; 161: 251-256
57. Zilinskas RA. Iraq's biological weapons. The past as future? JAMA 1997; 278: 418-424